NCT01536600View on ClinicalTrials.gov

Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 Diabetes

CompletedOBSERVATIONAL

Enrollment

33,010

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

biphasic insulin aspart 30

The insulin dose and regimen was individualised at the physician's discretion

Trial Locations (1)

137-920

Novo Nordisk Investigational Site, Seoul

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY